The ERK Pathway: Molecular Mechanisms and Treatment of Depression.
In: Molecular Neurobiology, Jg. 56 (2019-09-01), Heft 9, S. 6197-6205
Online
academicJournal
Zugriff:
Major depressive disorder is a chronic debilitating mental illness. Its pathophysiology at cellular and molecular levels is incompletely understood. Increasing evidence supports a pivotal role of the mitogen-activated protein kinase (MAPK), in particular the extracellular signal-regulated kinase (ERK) subclass of MAPKs, in the pathogenesis, symptomatology, and treatment of depression. In humans and various chronic animal models of depression, the ERK signaling was significantly downregulated in the prefrontal cortex and hippocampus, two core areas implicated in depression. Inhibiting the ERK pathway in these areas caused depression-like behavior. A variety of antidepressants produced their behavioral effects in part via normalizing the downregulated ERK activity. In addition to ERK, the brain-derived neurotrophic factor (BDNF), an immediate upstream regulator of ERK, the cAMP response element-binding protein (CREB), a transcription factor downstream to ERK, and the MAPK phosphatase (MKP) are equally vulnerable to depression. While BDNF and CREB were reduced in their activity in the prefrontal cortex and hippocampus of depressed animals, MKP activity was enhanced in parallel. Chronic antidepressant treatment readily reversed these neurochemical changes. Thus, ERK signaling in the depression-implicated brain regions was disrupted during the development of depression, which contributes to the long-lasting and transcription-dependent neuroadaptations critical for enduring depression-like behavior and the therapeutic effect of antidepressants. [ABSTRACT FROM AUTHOR]
Copyright of Molecular Neurobiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
The ERK Pathway: Molecular Mechanisms and Treatment of Depression.
|
---|---|
Autor/in / Beteiligte Person: | Wang, John Q. ; Mao, Limin |
Link: | |
Zeitschrift: | Molecular Neurobiology, Jg. 56 (2019-09-01), Heft 9, S. 6197-6205 |
Veröffentlichung: | 2019 |
Medientyp: | academicJournal |
ISSN: | 0893-7648 (print) |
DOI: | 10.1007/s12035-019-1524-3 |
Sonstiges: |
|